Table 4.

Sensitivity analysis of dyslipidemia among included study in Africa, 2021.

Study omitted	Country	Study participant	Estimate	[95% CI]
Kemal et al. (16)	Ethiopia	Patients on ART	51.9	39.7	64.1
Kiplagat et al. (32)	Kenya	Type-2 DM	51.4	39.3	63.6
Abdu et al. (33)	Ethiopia	Patients with H. Pylori	51.8	39.6	63.9
Haile et al. (34)	Ethiopia	Diabetes patients	52.2	39.9	64.4
Bekele et al. (35)	Ethiopia	Diabetes patients	52.2	40.0	64.5
Sufa et al. (8)	Ethiopia	General population	53.6	41.3	65.9
Okpala et al. (30)	Nigeria	Lichen Planus patients	54.4	42.1	66.7
Yusuf et al. (36)	Nigeria	Lichen Planus patients	53.9	41.6	66.2
Fikremariam et al. (37)	Ethiopia	Diabetes patients	51.5	39.3	63.7
Ditorguéna et al. (38)	Togo	General population	52.5	40.3	64.8
Amberbir et al. (39)	Malawi	HIV patients	54.5	42.0	66.9
Tilahun et al. (2)	Kenya	HIV patients	53.1	40.8	65.4
Ciccacci et al. (40)	Mozambique	DM and HTN patients	53.1	40.8	65.4
Hamooya et al. (41)	Zambia	HIV patients	54.0	41.6	66.4
Gebreegziabiher et al. (17)	Ethiopia	General population	52.7	40.5	65.0
Doupa et al. (42)	Senegal	General population	52.3	40.1	64.4
Asiki et al. (43)	Uganda	General population	52.0	41.9	62.1
Tadewos et al. (44)	Ethiopia	HIV	52.6	40.3	64.8
Ayoadea et al. (45)	Nigeria	HTN patients	52.5	40.3	64.8
Dave et al. (14)	South Africa	HIV	51.2	40.0	62.5
Jamieson et al. (31)	South Africa	HIV	54.9	40.0	71.9
Pitso et al. (46)	South Africa	Diabetes	51.5	39.3	63.7
Innes et al. (47)	South Africa	HIV	53.4	41.1	65.7
Gebreyes et al. (13)	Ethiopia	General population	54.9	38.0	71.8
Combined			52.8	40.8	64.9